Sökning: "apixaban"

Visar resultat 1 - 5 av 7 avhandlingar innehållade ordet apixaban.

  1. 1. Venous thromboembolism: Risk factors, comorbidities, and treatment-associated risk of bleedings

    Författare :Katarina Glise Sandblad; Göteborgs universitet; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Venous thromboembolism; Registries; Overweight; Body mass index; Incidence; Cardiovascular disease; Anticoagulants; Apixaban; Rivaroxaban; Warfarin; Hemorrhage;

    Sammanfattning : Background: Venous thromboembolism (VTE) is the third most common cardiovascular disease, consisting mainly of deep vein thrombosis (DVT) and pulmonary embolism (PE). Since VTE often is a preventable disease, knowledge of risk factors is critical. Following a VTE, many patients are subjected to extended anticoagulant treatment. LÄS MER

  3. 2. Oral anticoagulation and stroke risk

    Författare :Vilhelm Sjögren; Anders Själander; Per Wester; Peter J Svensson; Mia von Euler; Umeå universitet; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Stroke; warfarin; atrial fibrillation; dabigatran; rivaroxaban; apixaban; low-molecular-weight heparin; bridging;

    Sammanfattning : Background: The risk of ischaemic stroke in patients with atrial fibrillation (AF) and mechanical heart valve (MHV) prostheses can be reduced by oral anticoagulation (OAC), which increases the risk of serious bleeding. The aims of this thesis were [1] to find out how effective and safe warfarin is where treatment quality is high, i.e. LÄS MER

  4. 3. Monitoring of the oral anticoagulants apixaban and rivaroxaban to optimize individual safety and efficacy

    Författare :Fadiea Al-Aieshy; Karolinska Institutet; Karolinska Institutet; []
    Nyckelord :;

    Sammanfattning : The oral anticoagulants apixaban and rivaroxaban are administered at fixed doses without requiring routine monitoring. However, there is a dose and exposure dependency in efficacy and safety, and monitoring the anticoagulants may improve treatment outcomes. LÄS MER

  5. 4. Effects of direct oral anticoagulant treatment on hemostasis in patients with atrial fibrillation

    Författare :Viktor Schutz Taune; Karolinska Institutet; Karolinska Institutet; []
    Nyckelord :;

    Sammanfattning : The direct oral anticoagulants (DOAC) – dabigatran, rivaroxaban, apixaban and edoxaban – were approved without the need for routine monitoring. However, in parallel with clinical implementation, studies on how to measure the effect of DOACs have become a research area of increasing interest during the last decade. LÄS MER

  7. 5. Adherence to drug treatment and interpretation of treatment effects

    Författare :Erik Berglund; Per Lytsy; Ragnar Westerling; Tove Hedenrud; Uppsala universitet; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Medication adherence; Health-seeking behaviour; Chronic treatment; Cardiovascular treatments; Anticoagulants therapeutic use; Treatment outcome; Effect measure; Quality of care; Medical decision-making; Necessity-concern framework; Choice behaviour; Risk communication; Risk perception; Health communication; Social Medicine; Socialmedicin;

    Sammanfattning : Suboptimal adherence to medical treatments is prevalent across several clinical conditions and can lead to treatment failure. Adherence is a far from fully explored phenomenon and there is little knowledge about how patients interpret treatment effects. LÄS MER